Every Form 4 that The Scotts Miracle-Gro Company (SMG) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow SMG and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full SMG filings page.
Scotts Miracle-Gro director Stephen L. Johnson reported two stock awards. On January 30, 2026, he acquired 112 common shares of SCOTTS MIRACLE-GRO at $64.22 per share, bringing this holding to 27,520 shares.
On the same date, Johnson also received 3,271 common shares at a price of $0, described as Deferred Stock Units issued in lieu of a $7,188 retainer. After this grant, his directly held common shares increased to 30,791.
Scotts Miracle-Gro Chairman & CEO James Hagedorn, also a director and more than 10% owner, reported equity-related changes in his holdings. On January 30, 2026, he received a stock option grant for 142,315 common shares with an exercise price of $64.22 per share, expiring between January 30, 2029 and January 30, 2036. He also acquired 38.513 common shares at $51.93 per share, bringing his directly held common shares to 104,112.9728. In addition, he reported indirect holdings of 31,533.64 common shares through a 401(k) plan and 997,910 common shares through Hagedorn Partnership, L.P., reflecting his proportionate and family pecuniary interests.
Scotts Miracle-Gro director Brian E. Sandoval reported routine equity awards and vesting activity. On 01/30/2026, he acquired 448 common shares at $64.22 as deferred stock units issued in lieu of a $28,750 director retainer, and 3,271 additional common shares at $0.
On 02/02/2026, 182 restricted stock units, including dividend equivalent rights from a grant of 1,398 units awarded on February 3, 2023, converted into 182 common shares on a one-for-one basis. After these transactions, he directly owned 18,387 common shares and 972 dividend equivalent rights. The filing reflects compensation and vesting rather than an open‑market sale.
Scotts Miracle-Gro director Mark D. Kingdon reported acquiring additional company stock. On January 30, 2026, he acquired 3,271 common shares of The Scotts Miracle-Gro Company at a stated price of $0 per share.
Following this transaction, Kingdon directly beneficially owned 11,493 common shares of Scotts Miracle-Gro. The filing lists him as a director and shows no derivative securities transactions for this date.
Scotts Miracle-Gro executive Dimiter Todorov, EVP, Chief Legal Officer and Corporate Secretary, received a grant of stock options on January 30, 2026. The award covers 18,976 stock options with an exercise price of $64.22 per common share and expires on January 30, 2036.
Scotts Miracle-Gro executive Mark J. Scheiwer, EVP, CFO & CAO, reported an award of phantom stock on 01/26/2026. He received 10.367 phantom stock units at a reference price of $62.70 per unit, increasing his phantom stock holdings to 1,207.573 units, held directly.
Each phantom stock unit represents the right to receive one common share of Scotts Miracle-Gro or its cash value. These phantom stock units are payable in cash after his employment with the company ends, and he may transfer the units into an alternative investment at any time.
Scotts Miracle-Gro Chairman and CEO James Hagedorn received 1,329.114 phantom stock units on January 26, 2026. These units were valued at $62.7 per phantom share and are linked to Scotts Miracle-Gro common shares.
After this award, Hagedorn beneficially owns 233,802.271 phantom stock units directly. Each phantom unit represents the right to receive one common share of the company or its cash value, generally payable in cash after his employment with the company ends.
The Scotts Miracle-Gro Company executive Mark J. Scheiwer reported a small share acquisition through a company retirement plan. On 12/31/2025, he acquired 3.104 common shares of Scotts Miracle-Gro at $48.32 per share, coded as transaction type J. After this transaction, he beneficially owned 15,285.853 common shares directly and 493.482 common shares indirectly through a 401(k) plan. Scheiwer is listed as the company’s EVP, CFO & CAO, and this Form 4 is filed for a single reporting person.
Scotts Miracle-Gro Company Chairman and CEO James Hagedorn, a director and more than 10% owner, reported several equity transactions in company common shares. On January 2, 2026, 941.612 phantom stock units were settled for the same number of common shares, and 42.377 shares were disposed of, typically reflecting shares withheld to cover obligations. A prior credit of 41.391 common shares on December 31, 2025, is also reported.
Following these transactions, Hagedorn beneficially owned 104,074.4598 common shares directly, 31,533.64 shares through a 401(k) plan, and 997,910 shares indirectly through Hagedorn Partnership, L.P. He also continued to hold 232,473.157 phantom stock units, each economically equivalent to one common share, which are payable in cash following termination of employment or may be moved into alternative investments.
Scotts Miracle-Gro Company executive reports a small share acquisition. Executive Vice President & Chief of Staff Christopher J. Hagedorn filed a Form 4 showing that on 12/31/2025 he acquired 4.491 common shares of Scotts Miracle-Gro at a price of $48.32 per share, in a transaction reported under code J. Following this transaction, he beneficially owned 60,111.2874 common shares, held in direct ownership.
The Scotts Miracle-Gro Company executive Mark J. Scheiwer reported acquiring 9.846 phantom stock units on 12/26/2025 at a reference price of $57.76 per unit. Each phantom stock unit represents the right to receive one common share of Scotts Miracle-Gro or the cash value of a share. These phantom stock units are payable in cash following the end of his employment with the company, and he may transfer them into an alternative investment at any time. After this transaction, Scheiwer beneficially owned 1,197.206 phantom stock units held directly.
Scotts Miracle-Gro Company insider James Hagedorn, who serves as Chairman, CEO, director and a 10% owner, reported receiving new phantom stock units tied to the company’s common shares. On 12/26/2025, he acquired 1,563.94 phantom stock units at $57.76 per unit. Each phantom stock unit represents the right to receive either one common share or the cash value of a share.
Following this grant, Hagedorn beneficially owns 233,414.769 phantom stock units on a direct basis. These units are payable in cash after his employment with the company ends, and he may transfer the phantom stock into an alternative investment at any time, according to the disclosure.
The Scotts Miracle-Gro Company director reports a routine equity-related transaction. On 12/05/2025, a director of Scotts Miracle-Gro Co. filed a Form 4 detailing the accrual of 121 dividend equivalent rights tied to existing deferred stock unit (DSU) or restricted stock unit (RSU) grants. These dividend equivalent rights become exercisable proportionately with the DSUs or RSUs they relate to, and each right is the economic equivalent of one common share of the issuer.
Following this transaction, the reporting person held 783 derivative securities directly. The filing reflects standard equity compensation mechanics rather than a cash transaction in the company’s stock.
The Scotts Miracle-Gro Company executive reports derivative equity awards. EVP, CFO & CAO Mark J. Scheiwer filed a Form 4 showing two transactions dated 12/05/2025. He acquired 50 dividend equivalent rights, each economically equal to one common share of Scotts Miracle-Gro, bringing his total beneficially owned derivative position in this award type to 363 units. He also acquired 14.07 shares of phantom stock, increasing his phantom stock balance to 1,187.36 units. Dividend equivalent rights accrue on DSU or RSU grants and become exercisable proportionately with the related awards, while each share of phantom stock represents the right to receive one common share or its cash value, generally payable in cash after employment ends.
Scotts Miracle-Gro Company director files Form 4 for derivative award. A company director reported acquiring 18 dividend equivalent rights on December 5, 2025, tied to existing deferred stock unit (DSU) or restricted stock unit (RSU) grants. These rights become exercisable in step with the related DSUs or RSUs and each right is the economic equivalent of one common share of Scotts Miracle-Gro. Following this transaction, the director beneficially owned 33 derivative securities in direct ownership form.
Scotts Miracle-Gro director David C. Evans reported a routine equity-related change in ownership. On 12/05/2025, he acquired 121 dividend equivalent rights linked to deferred stock units (DSUs) or restricted stock units (RSUs). Each dividend equivalent right is described as the economic equivalent of one common share of Scotts Miracle-Gro. Following this transaction, Evans beneficially owned 783 derivative securities, held directly. These rights accrue on prior DSU or RSU grants and become exercisable proportionately with the underlying units.
Scotts Miracle-Gro director reports derivative equity accruals. A Form 4 filing shows director Nick Miaritis reported a transaction dated 12/05/2025 involving dividend equivalent rights linked to deferred stock units (DSUs) or restricted stock units (RSUs) of Scotts Miracle-Gro Co. (SMG).
The filing reports the acquisition of 37 dividend equivalent rights, which are derivative securities that become exercisable proportionately with the related DSUs or RSUs. Each dividend equivalent right is described as the economic equivalent of one common share of Scotts Miracle-Gro. Following this transaction, Miaritis is shown as beneficially owning 130 derivative securities of this type, held directly.
The Scotts Miracle-Gro Company director Mark D. Kingdon reported a small equity-related award. On 12/05/2025, a Form 4 filing shows the acquisition of 106 dividend equivalent rights tied to existing deferred stock unit (DSU) or restricted stock unit (RSU) grants. Each dividend equivalent right is described as the economic equivalent of one common share of Scotts Miracle-Gro.
Following this transaction, Kingdon beneficially owned 612 derivative securities in total, held in direct ownership form. The filing clarifies that these dividend equivalent rights become exercisable proportionately with the underlying DSUs or RSUs, aligning their value with the company’s common shares over time.
The Scotts Miracle-Gro Company director reports additional derivative equity units. A reporting person serving as a director of The Scotts Miracle-Gro Company (SMG) filed a Form 4 disclosing a derivative equity transaction dated 12/05/2025. The filing shows an acquisition of 159 dividend equivalent rights, which are linked to previously granted deferred stock units (DSUs) or restricted stock units (RSUs).
According to the disclosure, each dividend equivalent right is the economic equivalent of one common share of Scotts Miracle-Gro and becomes exercisable proportionately with the related DSUs or RSUs. Following this transaction, the reporting person beneficially owns 948 derivative securities tied to common shares on a direct basis. This reflects routine equity-based compensation activity rather than a cash transaction.
The Scotts Miracle-Gro Company director reports routine equity-based compensation activity. A company director filed a Form 4 disclosing the acquisition of 42 dividend equivalent rights tied to existing deferred stock units (DSUs) or restricted stock units (RSUs) on 12/05/2025. After this transaction, the reporting person holds 150 derivative securities directly. The filing explains that each dividend equivalent right is economically equal to one common share of Scotts Miracle-Gro and vests proportionately with the related DSUs or RSUs, reflecting ongoing alignment of director compensation with shareholder interests rather than a cash transaction.
Scotts Miracle-Gro director reports dividend-equivalent award
A director of Scotts Miracle-Gro Co. reported a routine equity-related transaction involving derivative securities. On 12/05/2025, the reporting person acquired 187 dividend equivalent rights, recorded as an "A" (acquired) transaction. These rights are tied to existing deferred stock unit (DSU) or restricted stock unit (RSU) grants and become exercisable proportionately with the underlying DSUs or RSUs.
Each dividend equivalent right is described as the economic equivalent of one common share of Scotts Miracle-Gro. Following this transaction, the reporting person beneficially owned 1,210 derivative securities on a direct basis, reflecting ongoing participation in the company’s equity-based compensation programs rather than a change in control or role.
Scotts Miracle-Gro Chairman and CEO James Hagedorn, who is also a director and 10% owner, reported acquiring additional derivative equity in the form of phantom stock. On 12/05/2025, he received 2,751.65 shares of phantom stock, each representing the right to receive one common share of Scotts Miracle-Gro or the cash value of a share. Following this transaction, he beneficially owned 231,850.829 phantom stock units in total. These phantom stock shares are payable in cash after his employment with the company ends, and he may transfer the phantom stock into an alternative investment at any time.
The Scotts Miracle-Gro Company director reports routine equity-based compensation activity. A director of Scotts Miracle-Gro, identified in the signature block as Brian E. Sandoval, reported a transaction dated 12/05/2025 involving derivative securities tied to the company’s common shares. The filing shows the acquisition of 189 dividend equivalent rights related to existing deferred stock unit (DSU) or restricted stock unit (RSU) grants. Each dividend equivalent right is described as the economic equivalent of one common share of Scotts Miracle-Gro.
Following this transaction, the reporting person beneficially owns 1,154 derivative securities in direct form. According to the explanation, these dividend equivalent rights accrue on DSU or RSU grants and become exercisable proportionately with the underlying awards, aligning the director’s economic interests with those of common shareholders.
The Scotts Miracle-Gro Company director Edith Aviles reported an equity-related transaction involving derivative securities. On 12/05/2025, she acquired 121 dividend equivalent rights tied to deferred stock units (DSUs) or restricted stock units (RSUs). Each dividend equivalent right is the economic equivalent of one common share of Scotts Miracle-Gro. Following this transaction, she held 783 derivative securities on a direct ownership basis. These awards track the value of common shares but are reported separately from standard stock holdings.
Scotts Miracle-Gro Company executive Christopher J. Hagedorn, who serves as EVP & Chief of Staff, reported a small increase in his direct ownership of company stock. On 11/28/2025, he acquired 4.693 common shares of Scotts Miracle-Gro at a price of $46.24 per share in a non-open-market transaction coded "J."
Following this transaction, Hagedorn now beneficially owns 60,106.7964 common shares of Scotts Miracle-Gro, held directly. The filing was made as a Form 4 for a single reporting person, documenting his updated ownership position for investors and regulators.
The Scotts Miracle-Gro Company Chairman and CEO James Hagedorn, who is also a director and more than 10% owner of SCOTTS MIRACLE-GRO CO (SMG), reported a small change in his holdings. On 11/28/2025, a transaction coded "J" added 43.253 common shares at a price of $46.24 per share to his directly held position.
After this transaction, Hagedorn beneficially owned 103,135.0688 common shares directly, plus 31,533.64 common shares held through a 401(k) plan and 997,910 common shares indirectly through Hagedorn Partnership, L.P., reflecting his proportionate and family-related interests. No derivative securities were reported in this filing.
The Scotts Miracle-Gro Company executive reports small share acquisition
A senior executive of The Scotts Miracle-Gro Company, serving as EVP, CFO & CAO, reported a minor change in his holdings of the company’s common shares. On 11/28/2025, he acquired 3.244 common shares at a price of $46.24 per share, reported under transaction code J, which is used for other types of acquisitions or transfers. Following this transaction, he beneficially owned 15,282.749 common shares in a direct account and 493.482 common shares through a 401(k) plan. This filing reflects routine insider ownership reporting rather than a major corporate event.
The Scotts Miracle-Gro Company Chairman and CEO James Hagedorn reported a compensation-related transaction involving phantom stock tied to the company’s common shares. On 11/26/2025, he acquired 1,595.606 phantom stock units at a reference price of $56.61 per unit. Each phantom share represents the right to receive one common share of Scotts Miracle-Gro or the cash value of a share.
The phantom stock is payable in cash after his employment with the company ends, and he may transfer these units into an alternative investment at any time. Following this transaction, Hagedorn beneficially owned 229,099.179 derivative securities directly, reflecting his ongoing equity-linked stake in the company.
The Scotts Miracle-Gro Company executive reports new phantom stock awards. Executive Vice President, Chief Financial Officer and Chief Administrative Officer Mark J. Scheiwer, a reporting person for Scotts Miracle-Gro (SMG), reported two acquisitions of phantom stock tied to the company’s common shares. On 11/17/2025, he acquired 72.09 phantom stock units at a derivative security price of $56.07, bringing his total derivative securities beneficially owned to 1,163.244 units. On 11/26/2025, he acquired an additional 10.046 phantom stock units at a derivative security price of $56.61, increasing his holdings to 1,173.29 phantom stock units.
Each phantom stock unit represents the right to receive one common share of Scotts Miracle-Gro or its cash value, and these phantom shares are payable in cash after the end of Scheiwer’s employment. He may transfer his phantom stock into an alternative investment at any time.
James Hagedorn, Chairman, CEO and more-than-10% owner of Scotts Miracle-Gro, received a grant of 41,353 common shares on November 13, 2025. On the same date, 18,216 shares were withheld to satisfy tax liabilities at $58.40 per share. After these transactions he holds 103,091.8158 common shares directly, plus indirect interests in 31,533.640 shares via a 401(k) plan and 997,910 shares through Hagedorn Partnership, L.P., reflecting his and certain family members’ proportionate interests.
Christopher J. Hagedorn, EVP & Chief of Staff of The Scotts Miracle-Gro Company, reported equity transactions in company common shares. On 11/13/2025, he acquired 12,258 common shares at a price of $0 per share and disposed of 6,232 common shares at a price of $58.4 per share. Following these transactions, he reported beneficial ownership of 60,102.1034 common shares, held directly.
Scotts Miracle-Gro Company executive Dimiter Todorov reported insider transactions in company common shares. On 11/13/2025, he acquired 9,748 common shares at a price of $0, likely reflecting an equity award. On the same date, he disposed of 4,148 common shares at $58.4 per share. After these transactions, he directly owned 21,268 common shares of Scotts Miracle-Gro.
Scotts Miracle-Gro Company President and COO Nathan E. Baxter reported insider transactions in the company’s common shares. On 11/13/2025, he acquired 28,510 common shares at $0 per share, then disposed of 12,702 common shares at $58.4 per share in a transaction coded “F.” After these transactions, he beneficially owned 66,536.1148 common shares directly and 36,993 common shares indirectly through Hagedorn Partnership, L.P. For purposes of determining whether he is a more than 10% beneficial owner, he may be deemed to beneficially own the partnership-held shares under Exchange Act Rule 16a-1(a)(1).
The Scotts Miracle-Gro Company (SMG) reported an insider equity transaction by its EVP, CFO & CAO, Mark J. Scheiwer. On 11/13/2025, he acquired 11,520 common shares at a price of $0, increasing his directly held stake. On the same date, 4,880 common shares were disposed of at $58.4 per share, reported with transaction code “F,” which typically relates to tax or similar withholding tied to equity awards. After these transactions, he directly beneficially owned 15,279.505 common shares and indirectly held 493.482 common shares through a 401(k) plan.
Scotts Miracle-Gro (SMG) reported an insider transaction by an executive officer. On 10/31/2025, the EVP & Chief of Staff reported a Code J transaction involving 4.687 common shares at $46.3 per share. Following this activity, the officer beneficially owned 54,076.1034 shares, held directly.
Form 4 transactions like Code J are classified as “other” under SEC rules and can cover administrative or non-open-market events, as disclosed here.
Scotts Miracle-Gro (SMG) insider James Hagedorn (Chairman & CEO, Director, 10% Owner) reported a Form 4 transaction. On 10/31/2025, he recorded the acquisition of 43.196 common shares at $46.30 under transaction code J. Following the transaction, holdings were 79,954.8158 common shares directly, 31,533.64 indirectly via a 401(k) plan, and 997,910 indirectly by Hagedorn Partnership, L.P. A footnote states he may be deemed a beneficial owner of securities held by the partnership pursuant to Rule 16a-1(a)(1).
Scotts Miracle-Gro (SMG) reported an insider transaction by its EVP, CFO & CAO. On 10/31/2025, the officer acquired 3.24 common shares (Code J) at $46.3.
Following the transaction, the officer beneficially owns 8,639.505 shares directly and 493.482 shares indirectly by a 401(k) plan.
Scotts Miracle-Gro (SMG) executive Mark J. Scheiwe, EVP, CFO & CAO, reported an insider transaction on a Form 4. On 10/28/2025, he acquired 10.19 units of phantom stock (Transaction Code: A) at a price of $55.81 per unit, bringing his beneficially owned phantom stock to 1,091.154 units, held directly.
Each phantom stock unit represents the right to receive one common share of SMG or its cash value. These units are payable in cash following termination of employment, and the reporting person may transfer phantom stock into an alternative investment at any time.
The Scotts Miracle-Gro Company (SMG) reported an insider transaction by Chairman & CEO James Hagedorn. On 10/28/2025, he acquired 1,618.451 phantom stock units at $55.81 per unit. Following this transaction, he beneficially owned 227,503.573 derivative securities directly.
Each phantom stock unit represents the right to receive one common share or the cash value. These units are payable in cash following termination of employment, and the holder may transfer the phantom stock into an alternative investment at any time. Hagedorn is listed as Director, 10% Owner, and Officer.
Brian E. Sandoval, a director of The Scotts Miracle-Gro Company (SMG), reported a transaction on 10/01/2025 in which he received 493 common shares. The Form 4 shows the shares were issued as Deferred Stock Units in lieu of a retainer with a stated value of $28,750, and a per-share price of $58.38 is shown for the transaction. After the transaction the reporting person beneficially owned 14,486 shares. The filing was signed on behalf of Mr. Sandoval by an attorney-in-fact on 10/03/2025. The Form 4 indicates this was a single-person filing and lists the respondent's address at the issuer's headquarters in Marysville, Ohio.
Stephen L. Johnson, a director of Scotts Miracle-Gro Co (SMG), received 247 deferred stock units on 10/01/2025 issued in lieu of a retainer at an implied price of $58.38 per share, representing a value of $14,375. After the transaction the reporting person beneficially owned 27,408 common shares. The Form 4 was signed by an attorney-in-fact on 10/03/2025.
The filing shows a non-cash issuance of equity-linked units to a director as compensation rather than an open-market purchase or sale. The report is a routine Section 16 disclosure of a director's remuneration and resulting beneficial ownership level.
James Hagedorn, Chairman & CEO of Scotts Miracle-Gro Co (SMG), reported a transaction on Form 4 showing an acquisition on 09/30/2025 of 41.1015 common shares at a price of $48.66. Following the reported transaction the filing lists 79,911.6198 shares as directly beneficially owned. The Form 4 also discloses indirect holdings of 29,413.378 shares held through a 401(k) plan and 997,910 shares held by Hagedorn Partnership, L.P., of which the reporting person is a general partner. The filing explains the partnership holdings may cause the reporting person to be deemed a beneficial owner of more than 10% of the issuer's common shares. The form is signed by an attorney-in-fact on behalf of the reporting person with a signature date of 10/03/2025.
Christopher J. Hagedorn, Executive Vice President & Chief of Staff of The Scotts Miracle-Gro Company (SMG), reported a transaction dated 09/30/2025 on a Form 4 filed with the SEC. The filing shows an acquisition of 4.4595 common shares at a reported price of $48.66 per share. After the reported transaction, the filing lists 54,066.5295 shares beneficially owned. The Form 4 was signed by an attorney-in-fact and dated 10/03/2025.
SCOTTS MIRACLE-GRO CO (SMG) reporting person Mark J. Scheiwer, identified as EVP, CFO & CAO, reported a transaction on 09/30/2025. The filing shows a non-derivative acquisition recorded at a price of $48.66 and indicates total beneficial ownership following the transaction of 10,136.2655 common shares. The report also discloses 433.874 shares held indirectly through a 401(k) plan. The Form 4 is signed by an attorney-in-fact on behalf of the reporting person.
Christopher J. Hagedorn, EVP & Chief of Staff of The Scotts Miracle-Gro Company (SMG), reported a transaction on 09/05/2025 in the company’s common shares. The Form 4 records a transaction code J with an entry showing 2.6532 (listed under the V column) and a price of $62.5085. Following the reported transaction, the form lists 54,062.07 shares beneficially owned. The filing was signed on behalf of Mr. Hagedorn by an attorney-in-fact on 09/30/2025. No additional explanatory remarks are provided in the form.
Nathan Eric Baxter, President and COO and a director of Scotts Miracle-Gro Company (SMG), filed a Form 4 reporting transactions dated 09/05/2025. The filing shows a non-derivative acquisition with codes listed as J and V, a quantity shown as 19.5915 A at a price of $62.5085. Following the reported transactions the filing shows 50,728.1148 (listed with a “D” in the form) as the amount of securities beneficially owned, and separately discloses 36,993 held indirectly through Hagedorn Partnership, L.P. The form includes an explanatory note that the reporting person may be deemed to beneficially own Partnership-held shares under Rule 16a-1(a)(1). The Form 4 is signed by an attorney-in-fact on 09/30/2025.